The Board of InGeNA is pleased to announce the appointment of Edith Hurt as Acting Chair, following the resignation of Carl Stubbings as a result of him taking up a role as a non-executive director of Rhythm Biosciences Limited, a member of InGeNA.
The Board wishes to congratulate and thank Edith for taking on the acting role while a search is conducted for a permanent Independent Chair. Edith joined InGeNA as an independent non-executive director in January 2025 and has more than 10 years of commercial and not-for-profit non-executive director experience across the health, community and business sectors.
The Board and management of InGeNA express their sincere appreciation to Carl for his considerable contribution to the development and success of InGeNA. Carl was one of four Initial Elected Directors when InGeNA was incorporated in November 2023 and served as a nominee of Founding Member Genetic Technologies Limited until July 2024. He was subsequently appointed Independent Chair in December 2024, following the resignation of Kathryn Campbell.